南模生物
(688265)
| 流通市值：13.10亿 | | | 总市值：20.68亿 |
| 流通股本：4938.85万 | | | 总股本：7796.35万 |
| 报告期 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 流动资产: | | | | |
| 货币资金 | 81,602,566.53 | 200,731,445.41 | 67,932,808.65 | 107,867,774.76 |
| 应收票据及应收账款 | 134,686,583.41 | 112,118,916.27 | 120,033,157.58 | 125,933,788.36 |
| 其中：应收票据 | - | - | - | 871,528 |
| 应收账款 | 134,686,583.41 | 112,118,916.27 | 120,033,157.58 | 125,062,260.36 |
| 预付款项 | 3,579,265.48 | 2,037,806.85 | 2,229,043.52 | 1,218,851.09 |
| 其他应收款合计 | 1,905,533.91 | 1,879,489.12 | 2,807,808.64 | 3,609,143.1 |
| 存货 | 15,810,036.2 | 12,669,784.69 | 17,407,503.63 | 15,399,865.14 |
| 其他流动资产 | 8,931,914.72 | 8,485,732.08 | 10,842,822.68 | 9,067,591.49 |
| 流动资产平衡项目 | 0 | 0 | 0 | 0 |
| 流动资产合计 | 1,145,527,515.74 | 1,148,284,749.04 | 1,086,358,495.97 | 1,136,355,680.96 |
| 非流动资产: | | | | |
| 其他非流动金融资产 | 59,006,335.29 | 57,006,335.29 | 58,475,189.68 | 55,475,189.68 |
| 固定资产 | 257,401,676.66 | 262,397,156.11 | 268,616,161.65 | 275,678,857.97 |
| 在建工程 | 68,787,135.13 | 68,099,821.01 | 67,011,890.69 | 66,634,532.2 |
| 使用权资产 | 58,130,875.26 | 66,964,977.12 | 67,778,264.22 | 73,974,706.64 |
| 无形资产 | 240,089,745.94 | 241,310,349.7 | 241,183,180.88 | 242,396,826.59 |
| 长期待摊费用 | 54,489,842.63 | 58,759,923.58 | 63,142,972.18 | 65,724,599.59 |
| 递延所得税资产 | 26,745,881.23 | 25,765,160.66 | 26,958,533.35 | 25,048,027.92 |
| 其他非流动资产 | 936,602.04 | 768,061.56 | 2,794,345.28 | 2,804,831.81 |
| 非流动资产平衡项目 | 0 | 0 | 0 | 0 |
| 非流动资产合计 | 765,588,094.18 | 781,071,785.03 | 795,960,537.93 | 807,737,572.4 |
| 资产平衡项目 | 0 | 0 | 0 | 0 |
| 资产总计 | 1,911,115,609.92 | 1,929,356,534.07 | 1,882,319,033.9 | 1,944,093,253.36 |
| 流动负债: | | | | |
| 应付票据及应付账款 | 32,018,908.73 | 26,538,313.76 | 22,982,096.62 | 32,741,869.67 |
| 应付账款 | 32,018,908.73 | 26,538,313.76 | 22,982,096.62 | 32,741,869.67 |
| 合同负债 | 88,581,875.28 | 91,390,498.11 | 86,738,265.41 | 90,662,947.25 |
| 应付职工薪酬 | 15,795,589.31 | 28,165,870.5 | 19,113,144.09 | 23,565,303.05 |
| 应交税费 | 856,249.61 | 1,815,651.94 | 2,556,132.2 | 990,209.61 |
| 其他应付款合计 | 2,412,119.98 | 2,597,081.16 | 3,190,713.73 | 1,770,394.2 |
| 一年内到期的非流动负债 | 24,301,684.95 | 24,669,879.36 | 20,329,056.57 | 25,295,143.08 |
| 流动负债平衡项目 | 0 | 0 | 0 | 0 |
| 流动负债合计 | 163,966,427.86 | 175,177,294.83 | 154,909,408.62 | 175,025,866.86 |
| 非流动负债: | | | | |
| 租赁负债 | 46,661,034.06 | 52,746,162.2 | 56,907,043.31 | 58,807,736.67 |
| 递延收益 | 16,177,031.62 | 16,918,483.95 | 9,749,924.64 | 10,329,653.55 |
| 递延所得税负债 | 1,171,766.78 | 1,514,072.59 | 843,010.43 | 571,748.08 |
| 非流动负债平衡项目 | 0 | 0 | 0 | 0 |
| 非流动负债合计 | 64,009,832.46 | 71,178,718.74 | 67,499,978.38 | 69,709,138.3 |
| 负债平衡项目 | 0 | 0 | 0 | 0 |
| 负债合计 | 227,976,260.32 | 246,356,013.57 | 222,409,387 | 244,735,005.16 |
| 所有者权益(或股东权益): | | | | |
| 实收资本(或股本) | 77,963,513 | 77,963,513 | 77,963,513 | 77,963,513 |
| 资本公积 | 1,566,465,273.99 | 1,565,311,776.96 | 1,564,480,642.71 | 1,563,327,145.68 |
| 减:库存股 | 62,086,095.9 | 62,086,095.9 | 62,086,095.9 | 37,941,554.59 |
| 其他综合收益 | 348,079.29 | 391,345.04 | -177,534.01 | 224,171.09 |
| 盈余公积 | 20,162,524.6 | 20,162,524.6 | 17,735,223.2 | 17,735,223.2 |
| 未分配利润 | 80,286,054.62 | 81,257,456.8 | 61,993,897.9 | 78,049,749.82 |
| 归属于母公司股东权益平衡项目 | 0 | 0 | 0 | 0 |
| 归属于母公司股东权益合计 | 1,683,139,349.6 | 1,683,000,520.5 | 1,659,909,646.9 | 1,699,358,248.2 |
| 股东权益平衡项目 | 0 | 0 | 0 | 0 |
| 股东权益合计 | 1,683,139,349.6 | 1,683,000,520.5 | 1,659,909,646.9 | 1,699,358,248.2 |
| 负债和股东权益合计 | 1,911,115,609.92 | 1,929,356,534.07 | 1,882,319,033.9 | 1,944,093,253.36 |
| 公告日期 | 2025-04-29 | 2025-04-29 | 2024-10-31 | 2024-08-29 |
| 审计意见(境内) | | 标准无保留意见 | | |